Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine fumarate versus sufentanil for postoperative analgesia after laparoscopic radical gastrectomy
ChiCTR2500095364Phase 4Recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oliceridine and sufentanil in postoperative pain (2 arms), sponsored by Hangzhou First People's Hospital. Primary endpoint: Time of first postoperative flatus. Started Jan 2025; status: recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500095364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095364.